Vitek supplies IDIQ for VISN 23 MOD P00001 to add additional line items for newly approved FDA pharmaceuticals.
Ended Awarded Last action
- Contract number
- 36C26325N0120
- Awardee
-
Biomerieux Inc. UEI HCNVCMEG9NL6
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $29,092
Award facts
- Contract value 64% obligated
- $45,583.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Iowa City, IA 52246, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$16,491 | |
| Supplemental Agreement for work within scope | $787 | |
| Original award | $44,796 |
About this award
Biomerieux Inc., operating as Vitek Systems, Inc., was awarded a delivery order modification (MOD P00001) on October 1, 2024, under an Indefinite Delivery Indefinite Quantity (IDIQ) contract with Veterans Integrated Service Network 23 (VISN 23). The modification adds newly approved FDA pharmaceuticals and related line items to the existing contract vehicle, with a ceiling value of $45,583.15. The contract employs firm fixed-price pricing and has no set-aside designation, indicating Biomerieux's status as a specialized sole-source provider for its diagnostic platforms. Performance will occur in Iowa City, Iowa, with completion targeted for September 30, 2025. The funding originates from the Department of Veterans Affairs through VISN 23, the civilian Veterans Health Administration network serving Iowa and surrounding regions.
This delivery order represents a continuation of Biomerieux's ongoing supply relationship with the VA, reflecting the company's established role as a primary provider of advanced diagnostic solutions, including VITEK microbiological testing systems and reagents, to VA healthcare networks. The modification expands the contract's scope to accommodate newly FDA-approved pharmaceutical products, enabling VISN 23 to access Biomerieux's expanded product portfolio through the existing IDIQ vehicle. Such modifications are typical within the VA's diagnostic supply chain, allowing facilities to procure additional approved materials without requiring new competitive solicitations, thereby streamlining procurement and ensuring continuity of critical laboratory testing capabilities across the network.
Quick answers
Who was awarded contract 36C26325N0120?
36C26325N0120 was awarded to Biomerieux Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26325N0120 worth?
The government has obligated $29,092 on 36C26325N0120. Its current value, with exercised options, is $45,583.
Is contract 36C26325N0120 an order under another contract?
Yes. 36C26325N0120 is a delivery order under 36C26324D0006, an indefinite delivery contract.
Was contract 36C26325N0120 competed?
The extent of competition for 36C26325N0120 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award